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Abstract
Background: TEAD1 (TEA domain family member 1) is constitutively expressed in cardiac and skeletal muscles. It
acts as a key molecule of muscle development, and trans-activates multiple target genes involved in cell
proliferation and differentiation pathways. However, its target genes in skeletal muscles, regulatory mechanisms
and networks are unknown.
Results: In this paper, we have identified 136 target genes regulated directly by TEAD1 in skeletal muscle using
integrated analyses of ChIP-on-chip. Most of the targets take part in the cell process, physiology process, biological
regulation metabolism and development process. The targets also play an important role in MAPK, mTOR, T cell
receptor, JAK-STAT, calcineurin and insulin signaling pathways. TEAD1 regulates foxo3a transcription through
binding to the M-CAT element in foxo3a promoter, demonstrated with independent ChIP-PCR, EMSA and luciferase
reporter system assay. In addition, results of over-expression and inhibition experiments suggest that foxo3a is
positively regulated by TEAD1.
Conclusions: Our present data suggests that TEAD1 plays an important role in the regulation of gene expression
and different signaling pathways may co-operate with each other mediated by TEAD1. We have preliminarily
concluded that TEAD1 may regulate FoxO3a expression through calcineurin/MEF2/NFAT and IGF-1/PI3K/AKT
signaling pathways in skeletal muscles. These findings provide important clues for further analysis of the role of
FoxO3a gene in the formation and transformation of skeletal muscle fiber types.
Background
Myogenesis is a complex process regulated by a number
of transcription factors, including myogenic determina-
tion factors Myf5 and MyoD, and differentiation factors
myogenin, Myf4 and MEF2 [1]. Other factors, such as
the TEA domain transcription factor family, also play
vital roles in myogenesis. TEA domain proteins share a
conserved DNA binding domain and govern develop-
mental functions in a variety of animal and plant phyla
[2,3]. TEAD1 is a member of the TEA domain family.
Previous studies have indicated that TEAD1 is constitu-
tively expressed in cardiac and skeletal muscles in pigs,
mice and humans [4,5], and its disruption leads to heart
defect and embryonic lethality in mice [6]. TEAD1 regu-
lates the expression of many skeletal muscle-specific
genes through binding to the M-CAT motif (TEAD1
protein binding site) in the promoters [7,8]. The tran-
scriptional regulation of TEAD1 to muscle-specific
genes is implemented by co-operating with numerous
co-factors, including MEF2 [7], vestigial like 2 [9], vesti-
gial like 4 [10], and so on.
Although mouse TEAD1 gene has been cloned and its
DNA binding and trans-activation domains have been
characterized, the target genes of TEAD1 are unknown.
Considering the importance of TEAD1 to skeletal mus-
cle development and the challenge of identifying direct
gene targets of TEAD1 action, we have good reason to
believe that chromatin immunoprecipitation combined
with DNA microarray analysis (ChIP-on-chip) would be
an effective approach to identify direct target genes of
TEAD1. Moreover, we choose to focus on the adult ske-
letal muscle because it is a well-studied target of
TEAD1 function in development.
Here, we identified 136 promoters significantly bound
by TEAD1, and we found that 10 genes had more than
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categories and pathways of the target genes. Signifi-
cantly, we found an important target gene, FoxO3a,
w h i c hp l a y sac r i t i c a lr o l ei nm u s c l eg r o w t ha n dd e v e l -
opment. Our data illustrate that TEAD1 is a mediator of
skeletal muscle development.
Results
Identification of TEAD1-bound promoters by ChIP-on-chip
analysis
With the aim of identifying the promoters bound by
TEAD1, we performed ChIP-on-chip analysis. ChIP with
a TEAD1 antibody was done using mouse skeletal muscle
tissues. In two biological replicas, the promoter regions
of 136 genes showed a reproducible signal (GEO acces-
sion number: GSE26107). All genes detected by the
ChIP-on-chip assay are shown in Additional file 1, Table
S1. There are 10 genes (STOML1, F730014I05RIK,
RBM34, A630050E13RIK, ZFP473, ZFP120, WDR73,
TEF, SMARCAD1 and ARMCX1), which have more than
2 putative TEAD1 binding sites.
To gain further insight into the biological importance
of the target genes identified, we analyzed the functional
categories of the annotated genes by examining their
associated gene ontology. Most of the targets took part
in the cell process, physiology process, biological regula-
tion metabolism and development process (Figure 1).
We then carried out pathway analysis examining the
biological function of the targets, and have found that
the target genes mainly take part in MAPK, mTOR,
T cell receptor, JAK-STAT, calcineurin and insulin sig-
naling pathways. These pathways are related to cell pro-
liferation, differentiation, apoptosis, immunological
regulation, growth and development.
Validation of the FoxO3a gene with ChIP-PCR
In order to verify the importance of the FoxO3a gene
found with ChIP-on-chip, we analyzed its enrichment
using individual ChIP-PCR (primers used in Table 1).
b-actin w a su s e da san e g a t i v ec o n t r o l ,a n dCOL1A
(a1 chain of type I collagen) [11] was used as a positive
control. Amplified TEAD1-IP or IgG-IP DNAs along
with Input-DNAs from skeletal muscles of three mice
were pooled, with equal quantities of DNA from each
Figure 1 Gene Ontology (GO) classifications of biological processes of TEAD1 target genes. On the basis of the annotated genes that
matched our unique tags, GO analysis was carried out using the DAVID tool.
Table 1 Primers used in this paper
Primer
name
Primer sequnence
TEA-cdsF 5-CTAgctagcAACATGGAAAGGATGAGCGACT-3
TEA-cdsR 5-CCGctcgagTCAGTCCTTCACAAGCCTGTAGA-3
FOX-
promoterF
5-GGATTGTGAAGGTGCGATCTG-3
FOX-
promoterR
5-AGGTGTGTCACTGGACCCTCA-3
COL-F 5-GCCAGAGGTGCTGTCAC-3
COL-R 5-GGTGTGTCTGGCATGGCAG-3
FOX-forwardF 5-CCGctcgag GCAGTTGCTTTGTTCTGGTGAA-3
FOX-forwardR 5-CCCaagctt ACTCACAGGGAGCCTCAACCTA-3
FOX-reverseF 5-CCCaagctt GCAGTTGCTTTGTTCTGGTGAA-3
FOX-reverseR 5-CCGctcgagACTCACAGGGAGCCTCAACCTA-3
FOX-qpcrF 5-ATGTGACATGGAGTCCATCATCC-3
FOX-qpcrR 5-TGTCCACTTGCTGAGAGCAGAT-3
b-qpcrL 5-TGTACCCAGGCATTGCTGACA-3
b-qpcrR 5-GACTCATCGTACTCCTGCTTGCT-3
FOX-W 5-TGTGTGTTATTTTTGAGATGGAATGTGGGGCTGGCTGAA
CGGCT-3
FOX-T 5-TGTGTGTTATTTTTGAGATCTACCATGGGGCTGGCT
GAACGGCT-3
FOX-WB 5-TGTGTGTTATTTTTGAGATGGAATGTGGGGCTGGCT
GAACGGCT-3
siTEA-F1 5-GGUUCUUGCCAGAAGGAAATT-3
siTEA-R1 5-UUUCCUUCUGGCAAGAACCTG-3
siTEA-F2 5-GGGCGGACUUAAACUGCAATT-3
siTEA-R2 5-UUGCAGUUUAAGUCCGCCCAG-3
siTEA-F3 5-CACCUACCAGAGAAAUAUATT-3
siTEA-R3 5-UAUAUUUCUCUGGUAGGUGTT-3
siTEA-NF 5-UUCUCCGAACGUGUCACGUTT-3
siTEA-NR 5-ACGUGACACGUUCGGAGAATT-3
The restriction enzyme recognition sites are underlined.
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Validation of the enrichment of the FoxO3a gene with
ChIP-PCR is shown in Figure 2.
Confirmation of TEAD1 binding to the FoxO3a promoter
by EMSA
As described above, the TEAD1 binding site in the promo-
ter region of the FoxO3a gene was confirmed with inde-
pendent ChIP-PCR. We then employed EMSA assays to
directly address whether TEAD1 binds FoxO3a in vivo.
We synthesized specific oligonucleotides containing the
TEAD1 element present in the FoxO3a promoter in
EMSA experiments with nuclear extracts from mouse ske-
letal muscle tissues. As shown in Figure 3A, incubation of
skeletal muscle nuclear extracts with biotin-labeled
TEAD1-FoxO3a sequence produced a DNA-protein band
shift. These DNA-protein complexes were determined to
be specific to the TEAD1 site by successful competition
assays using excess unlabeled TEAD1-FoxO3a and mutant
TEAD1- FoxO3a oligonucleotides. To confirm the binding
of TEAD1 to the TEAD1-FoxO3a sequence, these EMSA
reactions were further incubated with anti-TEAD1 anti-
body. As shown in Figure 3B, the addition of this antibody
resulted in a supershifted complex in addition to the
D N A - p r o t e i nb a n d .T h e s ed a t ac o n f i r mt h ep r e s e n c eo f
TEAD1 in the nuclear protein complex that binds the
TEAD1 binding site of the FoxO3a promoter.
The TEAD1 sequence is required for maximal
transcriptional activity of the FoxO3a promoter in
C2C12 cells
Sequence analysis of a partial FoxO3a promoter revealed
the presence of several consensus DNA sequences
known to be required for the binding of muscle-specific
transcription factors (Figure 4). Among them are E12,
E47, MEF-2, MyoD, myogenin and TEAD1. To evaluate
the functional importance of TEAD1 in mediating the
transcriptional activity of the FoxO3a gene, the FoxO3a
promoter was tested by transient transfection assays in
C2C12 cells. We then cloned the FoxO3a promoter. If we
were correct in assuming that the clone sequence repre-
sents the promoter of FoxO3a mRNA, then it should
have promoter activity when inserted in the correct
orientation with the transcription start-site upstream of
the luciferase cDNA. The fragment was cloned in both
orientations (forward and reverse) upstream of the luci-
ferase cDNA and transfected into C2C12 cells, and pro-
moter activity was measured. As shown in Figure 5A,
only the fragment in forward orientation showed high
promoter activity, whereas the one in reverse orientation
did not. Importantly, the orientation showing promoter
activity was the correct orientation of the fragment to
drive FoxO3a mRNA transcription.
The ChIP-on-chip result shows that FoxO3a may be
activated by TEAD1. To determine if TEAD1 binding
influences the transcriptional activity of the FoxO3a
promoter, we co-transfected the FoxO3a promoter-
luciferase reporter construct with a TEAD1 expression
construct, and pcDNA3.1 was applied as a negative con-
trol (Figure 5B). We found that, as expected, TEAD1 over-
expression activated the FoxO3a promoter, and a 10-fold
increase in reporter activity was observed. Thus, we can
state that FoxO3a promoter was regulated by TEAD1. The
exact mechanism by which TEAD1 regulates the FoxO3a
promoter will be discussed further below (see Discussion).
Effect of TEAD1 on FoxO3a transcription
In order to characterize the effect of TEAD1 on FoxO3a
transcription, firstly, we designed an over-expression
experiment of TEAD1. We transiently transfected the
C2C12 cells, which constitutively expressed high levels
of TEAD1, measured using the pcDNA3.1 vector or
pcDNA-TEAD1 vector or lipofectamine 2000 control.
After 48 h, the cells were harvested and expression
of FoxO3a was assessed by quantitative real-time PCR
(Figure 6). The result showed that FoxO3a expression
doubled as compared to the control.
To further investigate the functional consequences of
aberrant expression of TEAD1, we knocked down
TEAD1 gene using the siRNA experiment. We first
determined the optimal conditions for the introduction
of the negative control siRNA with a FAM encoding
fluorescent protein like GFP. By adjusting the condi-
tions, we were ultimately able to express fluorescent
proteins in ~70% of cells (data not shown). Under those
optimized conditions, introduction of a mixture of three
siRNA oligos targeting TEAD1 in C2C12 cells resulted
in an 80% reduction in TEAD1 mRNA levels, as com-
pared with cells transfected with control siRNA. After
48 h the cells were harvested and expression of FoxO3a
w a sa s s e s s e db yq u a n t i t a t i v er e a l - t i m eP C R( F i g u r e7 ) .
FoxO3a expression was down-regulated by about 50%.
Figure 2 Validation of the enrichment of the FoxO3a gene with
ChIP-PCR using prepared TEAD1-IP, IgG-IP, and Input DNAs.
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tent, and they support the conclusion that TEAD1 is
specifically bound to and regulates the expression of the
FoxO3a gene. TEAD1 is also shown to be a mediator of
skeletal muscle development.
Discussion
ChIP-on-chip has emerged as a powerful tool for dis-
secting the complex network of regulatory interactions
between transcription factors and their targets. It pro-
vides a new approach for examining direct transcription
Figure 3 EMSA analysis of TEAD1 binding site in the FoxO3a promoter. Biotin-labeled oligonucleotide probes for the TEAD1 FoxO3a
binding site were incubated with mouse skeletal muscle extracts. Competition experiments were performed using a 100-fold excess of mutant
or unlabeled TEAD1 FoxO3a probes. Supershift assays were performed with anti-TEAD1 antibody. Arrows indicate the resulting bandshifts (FOX-
W: normal probe; FOX-T: mutant probe; FOX-WB: unlabeled probe).
Figure 4 The TEAD1 sequence is required for maximal transcriptional activity of the FoxO3a promoter in C2C12 cells, revealed by
bioinformatics analysis. The graphical representation shown is the sequence of a partial promoter of the FoxO3a gene. The cis-sequences are
shown in boldface and underlined.
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not rely on previous characterization of a consensus
sequence or a prior knowledge of gene expression pat-
terns. In addition, we also used EMSA and the luciferase
reporter system to verify the biological reliability of
ChIP-on-chip data.
GO enrichment analysis shows that TEAD1 subtly
regulates a large number of genes involved in the cellu-
lar process including cell proliferation, differentiation,
growth, death and so on. In addition, some of the target
genes of TEAD1 take part in MAPK, mTOR, T cell
receptor, JAK-STAT, calcineurin and insulin signaling
pathways. These pathways are related to cell prolifera-
tion, differentiation, apoptosis, immunological regula-
tion, growth and development. These results add an
additional layer of regulation to the effects of TEAD1 in
promoting cell growth and development. Our results are
in accordance with the reports suggesting that TEAD1
plays an important role in muscle development [12].
FoxO3a, a member of the Forkhead O (FOXO) family,
has been shown to be involved in the regulation of ske-
letal and smooth muscle differentiation, proliferation
and cell size regulation [13]. Mice lacking FoxO3a are
apparently normal at birth, but develop cardiac hyper-
trophy and heart failure later in adult life [14,15].
FoxO3a is also a downstream target of the phosphatidy-
linositol-3 kinase (PI3K)/AKT pathway. It controls two
decomposing systems of skeletal muscle proteins inde-
pendently: ubiquitin/proteasome and autophagy/lyso-
some. When FoxO3a is activated, it causes muscle
protein degradation and muscular atrophy through
autophagy function. However, PI3K/AKT can inhibit the
activity of FoxO3a, and hinder the atrophy process,
thereby regulating the muscle atrophy [16,17]. Elia et al
Figure 5 Transient-transfection assays of FoxO3a promoter-luciferase reporters. (A) A transient-transfection experiment in C2C12 cells was
performed with a segment of FoxO3a cloned in either the forward or reverse upstream orientation of luciferase. The y axis of the graph
represents the relative luciferase activity, with the transfected material shown on the x axis. The pGL3-Basic represents the luciferase vector
lacking a promoter. (B) A transient-transfection assay was performed with the FoxO3a promoter-luciferase reporter transfected into C2C12 cells in
the presence of a TEAD1 expression vector or the pCDNA3.1 vector as a control. The statistical significance of the differences between the
FoxO3a forward and FoxO3a reverse, FoxO3a with TEAD1 and FoxO3a with pcDNA3.1 were analyzed by the Student’s t-test, * P < 0.05.
Figure 6 Over-expression of TEAD1 experiment in C2C12 cells.
pcDNA3.1 vector or pcDNA-TEAD1 vector or lipofectamine 2000
control transiently transfected the C2C12 cells. FoxO3a expression
was up-regulated about 2-fold compared to the control.
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nal transduction cascade reciprocally regulates miR-1
expression through the FoxO3a transcription factor, and
miR-1 expression was related to muscle cell growth and
differentiation. All these results indicate that FoxO3a
plays a critical role in muscle growth and development,
thus, we have chosen this gene to validate as a potential
target gene of TEAD1, and provide the basis for further
function study.
TEAD1 can regulate transcription of the foxo3a gene
through the binding to the M-CAT element, demon-
strated with independent ChIP-PCR analysis, EMSA and
luciferase reporter system assay. It is interesting to note
that there is a miR-208b binding site in the antisense
strand of FoxO3a (data not shown). MiR-208b is a mus-
cle-specific miR, and plays redundant roles in the speci-
fication of muscle fiber identity by activating slow, and
repressing fast myofiber gene programs [19]. Therefore,
FoxO3a may play a key role in the process of the trans-
formation of muscle fiber types. The muscle fiber type
directly affects meat color, meat tenderness and intra-
muscular fat content. Therefore, future investigation of
the effect of FoxO3a on regulating the transformation of
muscle fiber types is essential.
MEF2 and NFAT bind in the promoter of FoxO3a
(data not shown), which leads us to suppose that FoxO3a
may take part in the calcineurin/MEF2/NFAT signaling
pathway to promote the formation and transformation of
skeletal muscle fiber types. At the same time, FoxO3a is
also a downstream target of the PI3K/AKT signaling
pathway [20]. Under normal conditions, PI3K and AKT
are activated through insulin or insulin-like growth
factor-1 (IGF-1) binding with their receptors, and then
FoxO3a is phosphorylated and deactivated, so skeletal
muscle can develop normally. When insulin resistance
occurs or IGF-1 is lacking, this pathway is inhibited.
FoxO3a is not phosphorylated, skeletal muscle protein is
degraded, which causes muscular atrophy, and conse-
quently, muscle fiber can not transform normally.
It was preliminarily concluded that TEAD1 regulates
FoxO3a expression through calcineurin/MEF2/NFAT
and IGF-1/PI3K/AKT signaling pathways in skeletal
muscles. However, it is not known whether calcineurin/
MEF2/NFAT functions as a downstream effector of the
IGF-1/PI3K/AKT pathway or there is some other rela-
tionship. This question needs further study.
In summary, despite the stringency of the integrated
analysis of ChIP and microarray data, novel TEAD1 can-
didate target genes were found and FoxO3a was shown
as being directly regulated by TEAD1. Our data thus sug-
gest that TEAD1 plays an important role in the regula-
tion of gene expression and that different signaling
pathways may co-operate with each other in a complex
network of TEAD1 transcriptional regulation. These
findings provide some important clues that will enable
further analysis of the role of the FoxO3a gene in forma-
tion and transformation of skeletal muscle fiber types.
Conclusions
Our current results provide the first insights into the tar-
get genes of TEAD1 transcription factor in skeletal mus-
cles, and the regulatory mechanisms and networks
involved. The over-expression and inhibition analysis
suggest that foxo3a was positively regulated by TEAD1.
Figure 7 Knock down of TEAD1 expression using siRNA. (A) C2C12 cells were treated with siRNA against TEAD1 (SiTEAD1) or negative
control (SiControl) or lipofectamine 2000 control (LipoControl) and western blot confirmed the suppression of TEAD1 in SiTEAD1 treated cells.
(B) qRT-PCR analysis of FoxO3a using RNA extracted from SiTEAD1 or SiControl or LipoControl. FoxO3a expression was down-regulated about
50% compared to b-actin.
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regulate FoxO3a expression through calcineurin/MEF2/
NFAT and IGF-1/PI3K/AKT signaling pathways in skele-
tal muscles. These findings illustrate that TEAD1 is a
mediator of skeletal muscle development, and also pro-
vide some important clues that will enable further analy-
sis of the role of the FoxO3a gene in the formation and
transformation of skeletal muscle fiber types.
Methods
Tissue sample collection and cell culture
All animal procedures were performed according to pro-
tocols approved by the Biological Studies Animal Care
and Use Committee of Hubei Province, P. R. Skeletal
muscle tissues were collected from adult Kunming mice,
t h e nf r o z e ni nl i q u i dn i t r o g e n ,a n ds t o r e da t- 8 0 ° C .
C2C12 cells were cultured in DMEM/high glucose sup-
plemented with 20% FBS, 100 units/ml penicillin and 100
μg/ml streptomycin and maintained at 37°C in 5% CO2.
Plasmid construction
The mouse TEAD1 and FoxO3a gene sequences were
obtained from GenBank (NM_009346 and NC_000076)
and were employed to designed primers (Table 1). For
this purpose, we utilized LA Taq (TaKaRa, Japan), and
cloned the amplicons into the pMD18-T (Takara) vector
for subsequent manipulation. The coding region of the
TEAD1 gene was excised from pMD18-T (Takara) by
NheI-XhoI digestion, and blunt-end ligated into the
pcDNA3.1 to construct the expression vector pcDNA-
TEAD1. Using the same method, the promoter of
FoxO3a containing the TEAD1 binding site (5’-
CATTCCT-3’) was insert into the XhoI-HindIII and
HindIII-XhoI sites of the pGL3-Basic vector (Promega,
Madison, WI) to generate forward (+) and reverse (-)
luciferase reporter constructs (Figure 8). The reporter
vector pGL3-Basic does not contain any eukaryotic
promoter or enhancer elements. The forward vector was
defined as having the 1.865-kb insert ligated into pGL3-
Basic with the same 5’-3’ orientation relative to the
reporter gene as the native sequence in the genomic
clone relative to the FoxO3a gene.
Luciferase reporter assay
The C2C12 cells were seeded into 96-well plates at an
initial density of 60-80% and cultured overnight to
ensure adhesion and spreading. Co-transfections were
then performed using 0.5 μl of Lipofectamine 2000
reagent (Invitrogen, Carlsbad, CA, USA) with 200 ng of
the appropriate firefly luciferase plasmid DNA, and
20 ng of pRL-TK plasmid DNA (Promega) as an inter-
nal control. For co-transfection analyses, the levels of
reporter plasmids were kept constant, but 100 ng of
pcDNA-TEAD1 vector was added. The pGL3-Control
vector (Promega) was used as a positive control. The
transfection medium was removed and replaced with a
growth medium after 4 to 6 hours. Firefly and Renilla
luciferase activities were measured at 48 hours post-
transfection using the Dual-Glo Luciferase assay system
(Promega). The transfection efficiencies in each case
were normalized using the Renilla luciferase activity
levels and each construct was tested in triplicate in a
minimum of three independent experiments.
Validation of gene expression by qRT-PCR
qRT-PCR was performed using the SYBR Premix Ex
Taq Kit (TaKaRa) with cycling conditions consisting of
an initial 5 min at 95°C, followed by 35 cycles compris-
ing 15 sec at 95°C, 20 sec at 61°C, 20 sec at 72°C, and
fluorescence acquisition at 83°C for 1 sec. PCR (primers
used in Table 1) was then performed in triplicate and
the gene expression levels were quantified relative to the
expression of the b-actin gene using the Gene Expres-
sion Macro software (Bio-Rad, Hercules, Calif., USA),
Figure 8 Schematic representation of the pGL3-Basic vector and the relative positions of the restriction sites used in these
experiments. The arrow represents the direction of transcription of the vector. The (+) and (-) orientations are defined as the positioning of the
insert with respect to the luciferase gene in the same or reversed direction as it occurs with respect to the FoxO3a coding sequence.
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method. Dissociation curves were generated to ensure
that a single amplicon had been produced.
Western blot analysis
Western blot analyses were performed as described [21].
Total protein concentration in the samples was deter-
mined by the Bradford assay (Bio-Rad). Antibody against
TEAD1 was mouse monoclonal antibody from BD (BD
Transduction Laboratories, San Diego, CA). Anti-b-actin
antibody used as a control was a mouse monoclonal
antibody from Santa Cruz (Santa Cruz Biotechnology,
S a n t aC r u z ,C A ) .T h ei m a g e sw e r eq u a n t i f i e du s i n g
image J software from NIH.
siRNA and transfection
For TEAD1 knockdown studies, cells plated in 6-well
plates were transfected using Lipofectamine 2000
reagent. siRNA was designed by Invitrogen. Three
siRNA and control sequences targeting TEAD1 were
present (Table 1). Cells were harvested after 48 hours
and the RNA was isolated using an RNAEasy extraction
kit (Qiagen, Valencia, CA, USA).
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from mouse skeletal
muscles using the NE-PER Nuclear and Cytoplasmic
Extraction Reagents (Pierce, Rockford, IL). A double-
stranded oligonucleotide probe containing the putative
TEAD1 binding site was labeled at the 5’-end with bio-
tin by commercial company (Table 1). Incubation for
the DNA binding reaction was performed using the
Lightshift Chemiluminescent EMSA Kit (Pierce). For
competition experiments, a 100-fold excess of mutant
or unlabeled double-stranded oligonucleotide probe
(Table 1) was added to the reaction. For supershift
experiments, 3 μg of antibody against TEAD1 (BD) was
added to the reaction mixture and incubated with the
nuclear extracts at room temperature for 20 min before
the addition of the probe. Protein-DNA complexes were
electrophoresed on a 4% native polyacrylamide gel in
buffer containing 45 mmol/L Tris, 45 mmol/L boric
acid, and 1 mmol/L EDTA, pH 8.3, at 4°C. The samples
were then transferred to a positively charged nylon
membrane. Finally, a charge-coupled device camera
(FluorChem, Astec) was used to detect chemilumines-
cence on the membrane.
Chromatin immunoprecipitation
ChIP assays were performed on mouse skeletal muscles.
Briefly, 1 g of tissue was fixed with formaldehyde, neu-
tralized with glycine and rinsed with cold phosphate-
buffered saline. After lysis, samples were sonicated to an
average DNA length of 1000 bp (Figure 9). Following
chromatin sonication, the lysates were precipitated over-
night using 5 μg of mouse anti-TEAD1 monoclonal
antibody (BD) and anti-IgG antibody (BD) as a negative
control. Two independent ChIP experiments were per-
formed for each antibody. Protein A-agarose beads were
added to purify immune complexes. Cross-linking was
reversed by heating the samples overnight at 65°C. RNA
was degraded with RNase A for 4 h at 65°C, and pro-
teins were degraded by proteinase K treatment for 2 h
at 45°C. The DNA was further purified. The ChIP-cap-
tured DNA of samples, IgG DNA and the total input
DNA consisting of genomic DNA prepared from control
cross-linked tissues were prepared for amplification.
Promoter array hybridization, data analysis, statistics and
criteria of significance
To obtain the target genes of TEAD1, the mouse pro-
moter array, M8K (Aviva Systems Biology, San Diego,
CA), containing 8000 40-mer oligonucleotide probes tar-
geting gene promoters was used. The DNA samples
were amplified and labeled by Aviva’s ChIP-GLAS sys-
tem. Briefly, ChIP, IgG, and input DNAs were biotiny-
lated and annealed to the M8K-Oligo-Mix. The DNA
samples were then amplified by ligation mediated PCR
with T3 and T7 based primers (25 cycles), labeled with
Atto 550 or 647, and hybridized onto the chip. Amplifi-
cation, labeling, hybridization, and washing were carried
out according to the manufacturer’s instruction (Aviva,
AK-0524). Slides were scanned with the DNA Microar-
ray Scanner BA (Agilent Technologies, Santa Clara, CA,
USA) and intensities were extracted with the Feature
Extraction Software Version 9.1 (Agilent Technologies,
Santa Clara, CA, USA). Raw data were read into the R
statistical computation environment for preprocessing
Figure 9 Yield and size of DNA precipitated with anti-TEAD1
antibody from mouse skeletal muscle.
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subtracted from raw signals and negative values were
replaced with small positive ones. Signals were then nor-
malized using a variance stabilization method described
in [23,24] and implemented in the vsn Bioconductor
package [25]. Functional annotation of the target genes,
including classification and pathway analysis, was carried
out using the DAVID tool [26-28]. Promoter sequences
were analyzed for the presence of putative transcription
factor binding sites using the TESS (Transcription Ele-
ment Search System) web tool available from the Com-
putational Biology and Informatics Laboratory at the
University of Pennsylvania.
Additional material
Additional file 1: The target genes of TEAD1 obtained by ChIP-on-
chip. The table presents the target gene ID, gene symbol, gene
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